Hervé Lilliu

Over the past two decades in the biopharma industry (UCB, Pfizer, IMS), Hervé has been creating value for patients living with severe diseases by supporting the development, reimbursement, and commercialization of truly outstanding products. Prior to founding Inbeeo, Hervé has held diverse senior roles including Chief Market Access and Pricing Officer, Canadian Affiliate President and Global Commercial Lead. An economist by training, Hervé has gained a deep understanding of the global implications of the business having been based successively in Paris, London, Brussels, Toronto and Atlanta.

Shabri Mehta

Shabri has recently joined Inbeeo after finishing her university studies. Having completed an undergraduate degree specialising in Cell and Molecular Biology followed by a Master’s in Computer Science from UCL, Shabri has developed a keen interest in using technology in the life sciences. During her master’s degree Shabri has worked on a number of impactful projects, including a website application which uses machine learning to predict whether a patient will have a negative response after a surgery. Shabri is looking forward to utilising her technical skills at Inbeeo to analyze healthcare data and learn more about healthcare consulting.

Chris McDonald

Chris graduated from the University of York with a first class Masters degree in Chemistry, before going on to Imperial College London to complete his PhD in Membrane Biophysics and a post-doctoral position working on the development of a novel class of pharmaceuticals. Driven by a keen interest in the healthcare industry and a desire to transition into a more commercial environment, Chris has spent the last two years in medical consulting, developing key market access and health economic principles. During this time, he has enjoyed working on numerous projects spanning diverse areas including rare diseases, medical devices, oncology and virology. Chris is excited to apply these skills and experiences at Inbeeo to help life science companies create value for their customers. 

Pippa Macnair

Pippa graduated from the University of St Andrews with a first class degree in Geography, before going on to complete an MSc in Public Health (with distinction) at the London School of Hygiene and Tropical Medicine. During this time, she developed a strong interest in non-communicable diseases, with her final Masters thesis focusing on geographical variation in short-term mortality from colon cancer in the UK. Since graduating, Pippa has been working in medical consulting, developing her skills as a multi-disciplinary analyst with a focus on HTA and health economics. She now looks to apply these skills at Inbeeo, and develop her knowledge and expertise in market access and value-based pricing.  

Jean-Marc Frybourg

A graduate of ESCP-Europe and holding a Masters in Market Research and Marketing Strategy, Jean-Marc has 30 years of experience in the broader pharmaceutical industry - including biologics and animal health. After 9 years in pharmaceutical marketing, he gained a Masters in Health Economics at Paris Dauphine University in 1995. Since then, Jean-Marc held various Local, Regional and Global positions encompassing pricing and reimbursement, HEOR, health policy, and government affairs (Novartis, Sanofi Pasteur Vaccines, Pfizer, Shire, Merck, Indivior). Jean-Marc brings experience gained over a vast number of pricing and market access challenges ranging from identifying value for early R&D projects, to protecting products from price erosion during late-stage commercialisation.

Leyla Paydas

Leyla is a recent addition to Inbeeo team, having graduated from The University of Manchester with a degree in Neuroscience. Throughout her degree, she gained deep insight into neurodegenerative (Alzheimer’s, Parkinson’s) and psychiatric (depression, anxiety, schizophrenia) conditions by addressing their psychopathology, treatment and their mode of action as well as potential new drug targets. Through research, Leyla has investigated addiction and depression co-morbidity and its impact on how the brain processes emotions. Striving for a career within healthcare consulting, she is looking forward to developing her market access skills within a range of therapeutic areas.

Christopher Sayadian

Christopher earned a BSc in Molecular Biotechnology with a major in Drug Discovery and an MSc in Molecular and Cellular Biology (with distinction) from the University of Heidelberg, Germany, before reading for an MPhil in Developmental Biology and a PhD in Genetics at the University of Cambridge. He worked as a researcher at The Wellcome Trust / Cancer Research UK Gurdon Institute, the German Cancer Research Centre, and the European Molecular Biology Laboratory, and published his findings in high-impact journals. Having worked both in academia and the biotech industry, Christopher decided to shift gears and join inbeeo to help life science companies fully realize the value of the health technologies they develop.